TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVIĀ® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
HR or Marketing? Claim Your Free Employer Account
Adam Waldman ā Chief Commercial Officer at TG Therapeutics
Executive Bio
Adam Waldman joined TG Therapeutics in June of 2018 as the Chief Commercialization Officer. Most recently, Mr. Waldman served as the Head of Hematology-Oncology Marketing at Celgene Corporation where he spent the past thirteen years in various roles of increasing responsibility in sales, marketing and new product strategy. Adam brings extensive experience and a proven track record of success building high performing teams and launching transformational products in both hematology and oncology. Prior to Celgene, Mr. Waldman was at Schering Plough where he was responsible for coordinating the global marketing strategy for multiple oncology products. Mr. Waldman holds an MBA in Finance from the University of Rochester, Simon Business School, as well as a B.S. in Biological Science from Rutgers College.
Executive Team Culture Ratings from TG Therapeutics Employees
TOP
50%
TG Therapeutics' Executive Team scores in the Top 50%
of similar sized companies on Comparably
of similar sized companies on Comparably
TG Therapeutics' Executive Team at a Glance
Based on 18 ratings, TG Therapeutics' employees are less satisfied with their Executive Team and give them a āC+ā or 66/100. On average, Women provided higher ratings for their Executive Team compared to Men.
TG Therapeutics' Executive Team ranks in the Top 50% of other companies in Burlington, NC and Top 50% of other companies on Comparably that also have 201-500 Employees.
×